| 1 |
LU0942225912 |
Candriam Equities L Biotechnology, R - Capitalisation |
-10,67 % |
+19,87 % |
-0,65 |
| 2 |
LU1897414568 |
Janus Henderson Horizon Biotechnology Fund IU2 USD |
-15,88 % |
+27,24 % |
-0,67 |
| 3 |
LU0133360163 |
Candriam Equities L Biotechnology, I - Capitalisation |
-10,90 % |
+19,70 % |
-0,67 |
| 4 |
LU1897414485 |
Janus Henderson Horizon Biotechnology Fund H2 USD |
-16,02 % |
+27,22 % |
-0,67 |
| 5 |
LU1897414303 |
Janus Henderson Horizon Biotechnology Fund A2 USD |
-16,55 % |
+27,26 % |
-0,69 |
|
|
| 57 |
LU0976566496 |
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse W (acc) USD |
-20,52 % |
+21,57 % |
-1,06 |
|
|
| 73 |
LU0774687577 |
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse Z (acc) GBP |
-23,25 % |
+20,32 % |
-1,26 |
| 74 |
LU0415392835 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating |
-16,87 % |
+13,70 % |
-1,40 |
| 75 |
DE000A3DCA95 |
BIT Biotech Opportunities S |
-41,24 % |
+30,82 % |
-1,41 |
| 76 |
DE000A3DCBA0 |
BIT Biotech Opportunities I-II |
-41,32 % |
+30,81 % |
-1,42 |
| 77 |
LU0415392595 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating |
-17,45 % |
+13,70 % |
-1,44 |